U.S. pauses use of J&J vaccine over rare blood clots, rollout delayed in Europe (update 4)
U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson‘s COVID-19 vaccine for at least a few days after six women under age 50 developed rare ...